<div><p>Aims</p><p>To summarize our experience of radiofrequency catheter ablation (RFCA) for recurrent drug-refractory ventricular tachycardias (VTs) due to arrhythmogenic right ventricular cardiomyopathy (ARVC) in our center over the past 11 years and its related factors.</p><p>Methods and Results</p><p>We reviewed 48 adults (mean age 39.9 ± 12.9 years, range: 14 to 65) who met the present ARVC diagnostic criteria and accepted RFCA for VTs from December 2004 to April 2016. The patients received a total of 70 procedures using two ablation approaches, the endocardial approach in 52 RFCAs, and the combined epicardial and endocardial approach (the combined approach) in 18 RFCAs. Kaplan-Meier survival analysis showed that the combined approach...
Background: Atrial arrhythmias are present in up to 20% of patients with arrhythmogenic right ventri...
Background: Atrial arrhythmias are present in up to 20% of patients with arrhythmogenic right ventri...
Background: Radiofrequency catheter ablation (RFCA) is an alternative therapeutic management for dru...
To summarize our experience of radiofrequency catheter ablation (RFCA) for recurrent drug-refractory...
International audienceAims Studies assessing radiofrequency ablation (RFA) of ventricular tachycardi...
ObjectivesThis study sought to evaluate the outcomes of radiofrequency catheter ablation (RFA) of ve...
Background: It has been suggested that endocardial and epicardial ablation of ventricular tachycardi...
The roles of implantable cardioverter-defibrillators (ICDs) and radiofrequency catheter ablation (RC...
Aims The roles of implantable cardioverter-defibrillators (ICDs) and radiofrequency catheter ablatio...
Catheter ablation may reduce ventricular tachycardia (VT) burden in arrhythmogenic right ventricular...
AbstractAimsThis study analyzed the arrhythmogenic substrates and mechanisms of ventricular tachycar...
BACKGROUND The comparative efficacy of antiarrhythmic drug (AAD) therapy vs ventricular tachycardia...
Background: Atrial arrhythmias are present in up to 20% of patients with arrhythmogenic right ventri...
Background: Atrial arrhythmias are present in up to 20% of patients with arrhythmogenic right ventri...
Background: Radiofrequency catheter ablation (RFCA) is an alternative therapeutic management for dru...
To summarize our experience of radiofrequency catheter ablation (RFCA) for recurrent drug-refractory...
International audienceAims Studies assessing radiofrequency ablation (RFA) of ventricular tachycardi...
ObjectivesThis study sought to evaluate the outcomes of radiofrequency catheter ablation (RFA) of ve...
Background: It has been suggested that endocardial and epicardial ablation of ventricular tachycardi...
The roles of implantable cardioverter-defibrillators (ICDs) and radiofrequency catheter ablation (RC...
Aims The roles of implantable cardioverter-defibrillators (ICDs) and radiofrequency catheter ablatio...
Catheter ablation may reduce ventricular tachycardia (VT) burden in arrhythmogenic right ventricular...
AbstractAimsThis study analyzed the arrhythmogenic substrates and mechanisms of ventricular tachycar...
BACKGROUND The comparative efficacy of antiarrhythmic drug (AAD) therapy vs ventricular tachycardia...
Background: Atrial arrhythmias are present in up to 20% of patients with arrhythmogenic right ventri...
Background: Atrial arrhythmias are present in up to 20% of patients with arrhythmogenic right ventri...
Background: Radiofrequency catheter ablation (RFCA) is an alternative therapeutic management for dru...